Harvard 4th Annual Update in Neuro-Oncology 2024

Neuro-oncology is a rapidly evolving multi-disciplinary field, which involves the medical, radiation, and surgical management of pediatric and adult patients with primary and metastatic tumors of the central nervous system (CNS) and peripheral nervous system (PNS). In addition, modern molecular neuropathology and neuroradiology concepts are essential for accurate diagnosis and classification. This three-day CME course, Annual Update in Neuro-Oncology, is designed to provide an international audience with a comprehensive review of the diagnosis and management of pediatric and adult patients with primary and metastatic CNS and PNS tumors and neurological complications of cancer. Our target audience will be the providers involved in the care of adult and pediatric neuro-oncology patients (oncologists, radiation oncologists, neurosurgeons, neurologists, neuroradiologists, and neuropathologists). The course will also be of high relevance to nurse practitioners, physician assistants, psychologists, pharmacists, and nurses.
Who Should Attend

Specialty Physicians
Physician Assistants
Nurses
Pharmacists
Psychologists

Learning Objectives
Upon completion of this activity, participants will be able to:

Define the role of molecular biomarkers in the accurate diagnosis and classification of pediatric and adult CNS and PNS tumors.
Determine standard and novel treatment approaches to pediatric and adult CNS and PNS tumors.
Recognize and manage neurological complications associated with new cancer therapies.
Identify and manage long-term complications of CNS and PNS tumors and their treatment.

The Harvard 4th Annual Update in Neuro-Oncology 2024 is best for neurologists, oncologists, neurosurgeons, radiation oncologists, pathologists, and other professionals involved in the care of patients with central and peripheral nervous system tumors. It’s ideal for:
Who Should Attend

Clinicians treating primary and metastatic brain and spine tumors
Specialists managing neurological complications of cancer
Researchers and educators seeking updates on molecular diagnostics, neuroimaging, and multidisciplinary care

Dates: July 24–26, 2024
 
+ Topics:

Wednesday, July 24, 2024

10:00-10:10 AM Welcome: Pediatric Neuro-Oncology Session Scott Pomeroy, MD, PhD
10:10-10:25 AM Keynote: Targeted Therapy for Pediatric Low-Grade Glioma Karen Wright, MD
10:25-10:40 AM WHO Classification, Pediatric CNS Tumors Sanda Alexandrescu, MD
10:40-11:10 AM Advances in the Imaging of Pediatric Brain Tumors Tina Young Poussaint, MD, FACR

11:10-11:40 AM Embryonal Tumors Scott Pomeroy, MD, PhD

11:40 AM-12:00 PM Break

12:00-12:30 PM Pediatric Low-Grade Gliomas Susan Chi, MD

12:30-1:00 PM Pediatric High-Grade Gliomas Mariella Filbin, MD, PhD

1:00-1:15 PM Ependymomas Pratiti Bandopadhayay, MBBS, PhD

1:15-1:45 PM Live Q&A Session Scott Pomeroy, MD, PhD

1:45-2:00 PM Break

2:00-2:15 PM Choroid Plexus Tumors Viviana Benitez, MD

2:15-2:30 PM Pineal Tumors Shannon MacDonald, MD

2:30-2:45 PM Germ Cell Tumors Kee Kiat Yeo, MD

2:45-3:15 PM Neurofibromatosis Scott Plotkin, MD, PhD

3:15-3:30 PM Von Hippel Lindau Othon Iliopoulos, MD

3:30-3:45 PM Live Q&A Session Scott Pomeroy, MD, PhD

Thursday, July 25, 2024

10:00-10:05 AM Welcome: Adult Neuro-Oncology Bob Carter, MD, PhD
10:05-10:30 AM Keynote: CAR-T Cell Therapy for Glioblatoma Bryan Choi, MD, PhD
10:30-10:45 AM Advances in Surgery for Brain Tumors E. Antonio Chiocca, MD, PhD
10:45-11:00 AM Advances in Imaging for Brain Tumors Pamela Schaefer, MD, FACR
11:00-11:15 AM Advances in Radiation for Brain Tumors Helen Shih, MD
11:15-11:25 AM Live Question and Answer Session Bob Carter, MD, PhD
11:25-11:30 AM Break 11:30 AM-12:00 PM WHO Classification for Adult Gliomas Maria Martinez—Lage Alvarez, MD
12:00-12:30 PM Gliomas, IDH-Mutant ​​​​​Nicolas Gonzalez Castro, MD, PhD
12:30-12:45 PM Gliomas, IDH-Wildtype Isabel Arrillaga-Romany, MD, PhD
12:45-1:15 PM Advances in Experimental Therapies for Gliomas David Reardon, MD
1:15-1:30 PM Break 1:30-1:45 PM Meningioma Wenya Linda Bi, MD, PhD
1:45-2:00 PM CNS Lymphomas Tracy Batchelor, MD, MPH
2:00-2:15 PM Pituitary Tumors Pamela Jones, MD
2:15-2:45 PM Live Question & Answer Session Bob Carter, MD, PhD
2:45-2:50 PM Adjourn Bob Carter, MD, PhD

Friday, July 26, 2024

10:00-10:05 AM Welcome: Neurological Complications of Cancer Patrick Wen, MD
10:05-10:30 AM Keynote: The Oncogenic Origins of Temporal Lobe Epilepsy Sattar Khoshkhoo, MD
10:30-11:00 AM Metastases to the Brain Priscilla Brastianos, MD
11:00-11:15 AM Metastases to the Leptomeninges Jose Ricardo McFaline-Figueroa, MD, PhD
11:15-11:30 AM Metastases to the Epidural Space and Spinal Cord John Chi, MD, MPH
11:30-11:45 AM Live Question and Answer Session Patrick Wen, MD
11:45 AM-12:15 PM Break
12:15-12:30 PM Paraneoplastic Neurological Syndromes Eudocia Lee, MD, MPH
12:30-1:00 PM Common Neurological Complications in Cancer Patients Nancy Wang, MD
1:00-1:15 PM Neurological Complications of Cancer Immunotherapies Jorg Dietrich, MD, PhD
1:15-1:30 PM Managing Long-Term Survivors of CNS Tumors Deborah Forst, MD
1:30-1:45 PM The Role of the Neuropsychologist in Neuro-Oncology Michael Parsons, PhD, ABPP
1:45-2:00 PM Live Question and Answer Session Patrick Wen, MD
2:00-2:15 PM Closing Statements Tracy Batchelor, MD, MPH